The empty capsules market is projected to reach USD 4.2 billion by 2029 from an estimated USD 3.1 billion in 2024, at a CAGR of 6.3% during the forecast period. The major factors driving the growth of this market include increasing demand for nutraceuticals, growth in the pharmaceutical market, increasing number of clinical trials and R&D activities, and expansion of over-the-counter medications.
The global empty capsules market is competitive, with top players such as Capsugel (Lonza) (Switzerland), ACG (India), and QUALICAPS (Roquette Fréres) (France). To strengthen their position, the market players have adopted various strategies, such as new product launches, acquisitions, agreements, collaborations, and geographical expansions.
To know about the assumptions considered for the study download the pdf brochure
Capsugel (Lonza) (Switzerland)
Capsugel (Lonza) holds a prominent position in the empty capsules market with its extensive range of products. This includes vegetarian and gelatin capsules, catering to a wide range of dietary and pharmaceutical needs. The company is renowned for its stringent manufacturing standards, ensuring consistent and safe products. In addition, Cgpsggel (Lonza) places a strong emphasis on innovation and expanding its presence in the market to uphold its leadership position in the empty capsules sector.
In November 2022, the company introduced a new capsule specifically designed to deliver acid-sensitive active pharmaceutical ingredients to the intestine effectively. This launch highlights Cgpsggel (Lonza)’s dedication to addressing specific medical requirements and enhancing the efficacy of drug delivery. The company’s strategy revolves around continuous product development, leveraging advanced technology to meet specialized pharmaceutical demands, and expanding its global reach.
ACG (India)
ACG has established a wide-ranging presence across different regions, particularly in emerging markets, significantly strengthening its global outreach. The company offers various capsule varieties, including gelatin and HPMC capsules, to cater to various dietary and pharmaceutical requirements. Furthermore, ACG prioritizes strategic expansion efforts to maintain its dominant position in the empty capsules market. For instance, ACG invested approximately USD 100 million in December 2021 to construct Asia’s largest manufacturing facility in Aurangabad, Maharashtra. ACG has collaborated with the Maharashtra government to establish this colossal capsule manufacturing plant, which aims to double the company’s production capacity to 240 billion capsules annually. This expansion serves both the Indian and global markets. By embracing renewable energy, incorporating LEED design principles, and implementing advanced automation, ACG aligns its objectives with becoming a global leader in capsule manufacturing while simultaneously enhancing efficiency and sustainability.
QUALICAPS (Roquette Frères) (France)
QUALICAPS provides a diverse range of products, encompassing two-piece capsules and pharmaceutical processing equipment. By strategically establishing production facilities in key locations such as the US, Canada, Japan, Europe, and Brazil, the company ensures widespread availability and prompt responsiveness to customer requirements on a global scale. This extensive presence strengthens QUALICAPS’s capacity to meet diverse market demands while upholding stringent quality standards, strengthening its reputation as a trustworthy partner in the pharmaceutical and nutraceutical sectors.
Related Reports:
Empty Capsules Market by Type (Gelatin (Porcine, Bovine, Bonemeal), Non-gelatin (HPMC, Starch)), Functionality (Immediate-release, Sustained-Release, Delayed-release),Therapeutic Application (Antibiotic, Dietary, Antacid, CVD) — Global Forecast to 2029
